Guidance Sets FDA Deadlines For PMA Preapproval Factory Inspections
This article was originally published in The Gray Sheet
Executive Summary
FDA gives itself 140 days to review a PMA manufacturing section and inspect the firm's manufacturing operations under a 1draft guidance issued June 19